Tretinoin (Retinoic acid)
For research use only.
Catalog No.S1653 Synonyms: All-trans Retinoic Acid,ATRA
CAS No. 302-79-4
Tretinoin (Retinoic acid, All-trans Retinoic Acid, ATRA), which is a ligand for both the retinoic acid receptor (RAR) and the retinoid X receptor (RXR), can induce granulocytic differentiation and apoptosis in acute promyelocytic leukemia (APL) cells.
Selleck's Tretinoin (Retinoic acid) has been cited by 10 publications
1 Customer Review
Purity & Quality Control
Choose Selective Retinoid Receptor Inhibitors
|Description||Tretinoin (Retinoic acid, All-trans Retinoic Acid, ATRA), which is a ligand for both the retinoic acid receptor (RAR) and the retinoid X receptor (RXR), can induce granulocytic differentiation and apoptosis in acute promyelocytic leukemia (APL) cells.|
Tretinoin prevents the cytotoxicity of H2O2 in cultured human mesangial cells by increasing both the catalase activity and the reduced glutathione content, which are dose- and time-dependent changes. Tretinoin-incubated mesangial cells leads to increased levels of catalase mRNA and gamma-glutamyl-cysteine synthetase (catalytic subunit) mRNA, the latter being the rate-limiting step in de novo reduced glutathione synthesis.  Tretinoin upregulates matrix metalloproteinase-13 and matrix metalloproteinase-8 in human keloid-derived fibroblasts. 
|In vivo||Tretinoin-treated old male Fischer 344 rats have 30% lower protein content in the renal cortex than control old rats, this effect may depend on the inhibition of the expression of tumor necrosis factor-beta1, a matrigenic cytokine, and osteopontin, a protein with cell adhesive and chemotactic properties.  Tretinoin has the ability to prevent the major steroid-induced biomechanical changes in hairless mouse dermal connective tissue that contribute to atrophy.  Tretinoin combined with imiquimod leads to faded tattoos and moderate clearance of pigment on histopathology in the guinea pig.  Tretinoin increases fibroplastic proliferation in the Skin incisions were made in 45 CD-1 mice, but the production of collagen was diminished. |
-  Manzano VM, et al. J Pharmacol Exp Ther, 1999, 289(1), 123-132.
-  Uchida G, et al. Exp Dermatol, 2003, 12 ,Suppl 2, 35-42.
-  Schwartz E, et al. J Invest Dermatol, 1994, 102(2), 241-246.
|In vitro||DMSO||60 mg/mL (199.73 mM)|
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
|Storage||3 years -20°C(in the dark) powder
2 years -80°C(in the dark) in solvent
|Synonyms||All-trans Retinoic Acid,ATRA|
In vivo Formulation Calculator (Clear solution)
|Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)|
|Dosage||mg/kg||Average weight of animals||g||Dosing volume per animal||ul||Number of animals|
|Step 2: Enter the in vivo formulation ()|
|% DMSO % % Tween 80 % ddH2O|
Working concentration： mg/ml；
Method for preparing DMSO master liquid: ： mg drug pre-dissolved in μL DMSO (Master liquid concentration mg/mL，)
Method for preparing in vivo formulation：Take DMSO master liquid, next addμL PEG300， mix and clarify, next addμL Tween 80，mix and clarify, next add μL ddH2O，mix and clarify.
1.Please make sure the liquid is clear before adding the next solvent.
2.Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:
Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)
*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).
Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )
* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).
Molecular Weight Calculator
Enter the chemical formula of a compound to calculate its molar mass and elemental composition:
Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2
Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
Clinical Trial Information
|NCT Number||Recruitment||interventions||Conditions||Sponsor/Collaborators||Start Date||Phases|
|NCT04149418||Not yet recruiting||Other: Yogurt|Other: Control food||Obesity|Inflammation||University of Wisconsin Madison|National Dairy Council|University of Massachusetts Amherst||January 2021||Not Applicable|
|NCT03327064||Not yet recruiting||Drug: UAB30|Drug: Placebo||Non-melanoma Skin Cancer||University of Alabama at Birmingham||August 15 2020||Phase 1|Phase 2|
|NCT03999684||Completed||Drug: Tretinoin||Adenoid Cystic Carcinoma||Dana-Farber Cancer Institute|The V Foundation|ACCRF||August 5 2019||Phase 2|
|NCT03611595||Recruiting||Drug: Cabozantinib|Drug: 13-cis-retinoic acid||Solid Tumor||Peter Zage|Exelixis|University of California San Diego||August 28 2018||Phase 1|
|NCT03200847||Active not recruiting||Drug: Pembrolizumab with All-Trans Retinoic Acid||Stage IV Melanoma|Stage III Melanoma|Advanced Melanoma||University of Colorado Denver|Merck Sharp & Dohme Corp.||October 31 2017||Phase 1|Phase 2|
Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.